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Fanconi anaemia (FA) is a cancer predisposition syn-
drome characterized by cellular sensitivity to DNA
interstrand crosslinkers. The molecular defect in FA
is an impaired DNA repair pathway. The critical event
in activating this pathway is monoubiquitination of
FANCD2. In vivo, a multisubunit FA core complex
catalyzes this step, but its mechanism is unclear.
Here, we report purification of a native avian FA
core complex and biochemical reconstitution of
FANCD2 monoubiquitination. This demonstrates
that the catalytic FANCL E3 ligase subunit must be
embedded within the complex for maximal activity
and site specificity. We genetically and biochemi-
cally define a minimal subcomplex comprising just
three proteins (FANCB, FANCL, and FAAP100) that
functions as the monoubiquitination module. Resid-
ual FANCD2 monoubiquitination activity is retained
in cells defective for other FA core complex subunits.
This work describes the in vitro reconstitution and
characterization of this multisubunit monoubiquitin
E3 ligase, providing key insight into the conserved
FA DNA repair pathway.
INTRODUCTION
Fanconi anaemia (FA) is a rare, recessive disorder with a striking
phenotype consisting of developmental defects, bone marrow
failure, and cancer predisposition (Crossan and Patel, 2012). At
theheart ofFAaredeficiencies inanetworkofproteins that consti-
tute a conserved eukaryotic DNA repair pathway that targetsDNA
interstrand crosslinks and counteracts aldehyde genotoxicity
(Kim and D’Andrea, 2012; Langevin et al., 2011). FA patients har-
bor inactivating mutations in any one of 15 FANC genes (Kotte-
mann and Smogorzewska, 2013). In addition, five FA-associated
proteins (FAAPs) play roles in the FA DNA repair pathway.
A number of FANC and FAAP proteins (FANCA, FANCB,
FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM and858 Molecular Cell 54, 858–869, June 5, 2014 ª2014 The AuthorsFAAP20, FAAP24, and FAAP100) associate to form the FA core
complex (Hodson and Walden, 2012; Meetei et al., 2003b). After
DNA damage, this multisubunit E3 ligase carries out the specific
monoubiquitination of FANCI and FANCD2, a critical event that
initiates DNA repair (Garcia-Higuera et al., 2001; Knipscheer
et al., 2009;Smogorzewskaet al., 2007). Thesitesofmonoubiqui-
tination have beenmapped to the conserved lysine 561 in human
FANCD2 (K563 in chicken) and lysine 523 in human FANCI (K525
in chicken) (Garcia-Higuera et al., 2001; Ishiai et al., 2008; Mat-
sushita et al., 2005; Sims et al., 2007; Smogorzewska et al.,
2007). Ubiquitinated FANCD2 is a platform for the recruitment
of additional proteins that coordinate DNA repair. These include
the FAN1nuclease and the scaffold protein FANCP (SLX4), which
recruits the XPF-ERCC1, SLX1, and MUS81-EME1 nucleases
(Cybulski and Howlett, 2011; Huang and D’Andrea, 2010).
Mechanistic insight into the FA core complex is lacking
because it has yet to be purified in a form suitable for in vitro
biochemical characterization. Challenges stem from the large
number of subunits, their low abundance, and the absence of
orthologs in lower eukaryotic model organisms such as yeast
(Zhang et al., 2009). Other multisubunit E3 ligases, such as the
anaphase-promoting complex/cyclosome (APC/C) and Skp-
Cullin-F box (SCF) complex, function by precisely positioning
substrate proteins for ubiquitination by their really interesting
gene (RING) finger subunits (Zimmerman et al., 2010). Their com-
plex architectures allow extensive regulation. The mechanism of
the FA core complex is of particular interest because of itsmono-
ubiquitin ligase function (contrasting with either APC/C or SCF,
which form polyubiquitin chains), its central position in the FA
DNA repair pathway and its fundamental role in human health.
In vitro assays have been reconstituted with the FANCL RING
finger subunit in the absence of other FA core complex subunits
(Alpi et al., 2008; Longerich et al., 2009; Sato et al., 2012). RING
finger E3 ligases are known to specifically recruit E2 ubiquitin-
conjugating enzymes in order to allow ubiquitin transfer from
E2 onto a substrate. Ubiquitin conjugating enzyme 2T (UBE2T)
functions as an E2 enzyme for FANCL both in vitro and in vivo
(Alpi et al., 2008, 2007; Hodson et al., 2014; Machida et al.,
2006). A second E2 (UBE2W) binds FANCL and monoubiquiti-
nates FANCD2 in vitro (Alpi et al., 2008; Zhang et al., 2011),
but its role in the FA pathway has not been rigorously explored.
Recent experiments have also revealed that efficient recognition
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Figure 1. Generation and Validation of the
DFANCB/FANCB-GS DT40 Cell Line
(A) Schematic representation of generation of the
DFANCB/FANCB-GS cell line and the expected
effect on FANCD2 monoubiquitination in vivo.
G, the IgG binding domain of protein G; SBP,
streptavidin binding peptide.
(B) Targeting strategy for the generation of the
DFANCB cell line. Exons are shown in black (exons
5 and 6) or green (exons 7, 8, and 9) boxes. The
location of the Southern blot probe is in red.
DrugR, drug resistance cassette.
(C) Southern blot showing gene targeting of
FANCB. After BamHI digest, wild-type (WT) alleles
are 23 or 18 kb, whereas the knockout allele (KO) is
5.6 kb. A 6.5 kb fragment (#) is present in all cell
lines. Lane 1 shows a FANCB+/+ cell line, lane 2
shows FANCB+/, and lane 3 shows FANCB–/–.
(D) DFANCB/FANCB-GS cells regained the ability
to monoubiquitinate FANCD2 upon treatment with
1 mM hydroxyurea (HU) or 50 ng/ml mitomycin C
(MMC). Western blotting of FANCD2 mono-
ubiquitination in whole-cell extracts is shown for
WT DT40 cells, cells with a deletion of the genomic
FANCB gene (DB), and DB cells stably expressing
chicken FANCB with a C-terminal protein G and
streptavidin binding peptide tag (DB/B-GS).
Molecular Cell
Purification and Activity of FA Core Complexof FANCD2 by FANCL in vitro depends on the presence of its
binding partner FANCI and DNA (Sato et al., 2012). The roles of
other FA subunits are poorly defined, and they largely lack any
identifiable domains that could illuminate their function.
Here, we develop a purification strategy for isolating a native
FA core complex. The recovered complex is efficient at FANCD2
monoubiquitination in a cell-free system, and our biochemical
analysis points to a core subcomplex as being fundamental to
this reaction. Finally, genetic ablation studies confirm an essen-
tial role for components of this minimal subcomplex in vivo.
RESULTS
Purification of a Native FA Core Complex
We developed a purification strategy to isolate the FA core com-
plex from chicken DT40 cells, a vertebrate model used exten-
sively in the study of the FA pathway (Niedzwiedz et al., 2004;
Yamamoto et al., 2003). Our aimwas to generate a cell line where
the only copy of the FANCB subunit included an affinity purifica-
tion tag (Figure 1A). First, we deleted the genomic copies of
FANCB (Figures 1B and 1C). In wild-type cells, FANCD2 is
monoubiquitinated after exposure to DNA damage or replication
stress, for example, by the DNA crosslinking agent mitomycin CMolecular Cell 54, 858–(MMC) or the DNA synthesis inhibitor hy-
droxyurea (HU). This can bemonitored on
western blots by the appearance of a
slower migrating monoubiquitinated
form of FANCD2 (Figure 1D, lanes 2 and
3). DFANCB DT40 cells have a defective
FA pathway because they do not exhibit
FANCD2 monoubiquitination after MMCor HU treatment (Figure 1D, lanes 5 and 6), which is in agreement
with previous work in FA patient cells that lack functional FANCB
(Meetei et al., 2004).
Next, FANCB with a C-terminal protein G-streptavidin binding
peptide (GS) tag (Bu¨rckstu¨mmer et al., 2006) was used to com-
plement the DFANCB cells (Figure 1A). DFANCB/FANCB-GS
cells regained the ability to monoubiquitinate FANCD2 (Fig-
ure 1D, lanes 8 and 9). Thus, the tagged FANCB protein is
functional and restores the activity of the FA core complex
in vivo.
Using theDFANCB/FANCB-GSDT40 cell line, wewere able to
purify the FA core complex with IgG agarose using elution by
tobacco etch virus (TEV) cleavage and subsequent purification
on streptavidin resin with biotin elution, as shown in Figure 2A.
This yielded highly pure native FA core complex under physio-
logical conditions. The purified complex contains nine known
subunits whose identities were confirmed by western blotting
and mass spectrometry: FANCA, FANCB, FANCC, FANCE,
FANCF, FANCG, FANCL, FANCM, and FAAP100 (Figures 2B
and 2C and data not shown). Quantitative SDS-PAGE analysis
indicated that the subunits can be classified into three groups
on the basis of their relative abundances: FANCB-FANCL-
FAAP100 (B-L-100), FANCC-FANCE-FANCF (C-E-F), and869, June 5, 2014 ª2014 The Authors 859
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Figure 2. Purification of the Fanconi
Anaemia Core Complex
(A) FA core complex purification strategy.
(B) SDS-PAGE and silver stain analysis of the
purification of FA core complex from DFANCB/
FANCB-GS cells. Major species identified bymass
spectrometry (data not shown) are indicated.
(C) The presence of FANCGand FANCM in purified
FA core complex is confirmed by western blotting
with antibodies against the endogenous proteins.
The purified core complex was run on SDS-
PAGE alongside whole-cell extracts (WCE) from
DFANCG and DFANCM DT40 cells.
See also Table S1.
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Purification and Activity of FA Core ComplexFANCA-FANCG (A-G; Table S1 available online). The FANCM
subunit is present in very low abundance, whereas its associated
proteins (FAAP10, FAAP16, and FAAP24) and the FANCA-asso-
ciated protein FAAP20 are not detected in our purification. These
subunits are not essential for FANCD2monoubiquitination or the
structural integrity of the FA core complex in vivo but most likely
facilitate chromatin localization (Kim et al., 2008; Mosedale et al.,
2005; Singh et al., 2009, 2010; Yan et al., 2010). Thus, our puri-
fied FA core complex contains all subunits currently known to
be required for FANCD2 monoubiquitination, demonstrating
that a constitutively assembled core complex exists in asynchro-
nous dividing cells independent of DNA damage (Alpi et al.,
2007).
In Vitro FANCD2Monoubiquitination by Purified FA Core
Complex
The E3 ligase in the FA core complex is the RING-finger-contain-
ing FANCL subunit (Alpi et al., 2008; Cole et al., 2010; Meetei
et al., 2003a). The roles of other subunits are unclear. In vivo
mutation of any one of the core complex components is thought
to abolish FANCD2 monoubiquitination and lead to defective
DNA repair and disease (Garcia-Higuera et al., 2001). To investi-
gate the biochemical activity of the FA core complex, we recon-
stituted its monoubiquitination activity in vitro. We incubated
purified FA core complex with recombinant E1 ubiquitin-acti-
vating enzyme, UBE2T, HA-tagged ubiquitin, and the His-tagged
substrates FANCD2 and FANCI (Figures 3A and S1A–S1C). To
eliminate species incompatibilities, we used the chicken homo-
logs of UBE2T, FANCD2, and FANCI. We monitored monoubi-
quitination of His-FANCD2 and His-FANCI by western blotting.
In this assay, our purified FA core complex catalyzes the trans-
fer of ubiquitin onto FANCD2, as shown by the appearance of a
discrete slower migrating band above FANCD2 on both anti-His
and anti-HA western blots in Figures 3B and S1D (lanes 3 and 6).860 Molecular Cell 54, 858–869, June 5, 2014 ª2014 The AuthorsThe reaction goes to near completion at
late time points, where unmodified
FANCD2 is barely visible (Figure S1D,
lane 6). Thus, our purified complex is
active.
FANCD2 forms a complex in vivo with
FANCI, and both are monoubiquitinated
and recruited to sites of DNA damage inchromatin (Smogorzewska et al., 2007; Matsushita et al., 2005;
Montes de Oca et al., 2005). We found that the in vitro activity
of purified FA core complex is dependent on the presence of
FANCI and is greatly stimulated by 50-flapped DNA (Figure 3B),
reflecting the in vivo context of its activity.
The Intact FA Core Complex Is More Active and More
Specific than Isolated FANCL
As mentioned above, all previous in vitro studies of FANCD2
monoubiquitination had been performed with isolated FANCL
(Alpi et al., 2008; Sato et al., 2012). We sought to compare
this with the activity of our purified complex (Figures S1E
and S1F).
Strikingly, the FA core complex is much more active than re-
combinant chicken FANCL (Figure 4). First, approximately five
times more isolated FANCL is required to monoubiquitinate
FANCD2 to the same level as FA core complex (Figure 4A,
compare lanes 5 and 9; Figures S2A and S2B). Under these con-
ditions, the FA core complex is alsomore specific, given that only
isolated FANCL shows significant ubiquitin conjugation onto
itself and UBE2T (Figure 4A, HA blot lanes 8 and 9). Second,
when equimolar amounts of FA core complex and isolated
FANCL are used in a time course of FANCD2 monoubiquitina-
tion, the rate of FANCD2 monoubiquitination is dramatically
higher with FA core complex (Figures 4B, 4C, and S2C). Finally,
FA core complex ubiquitinates FANCD2 on only the physiologi-
cally relevant lysine 563 (Figure 4D), whereas FANCL exhibits
weak, but reproducible nonspecific, monoubiquitination of
FANCD2K563R (see Figure S3A, lanes 23 and 35) (Sato et al.,
2012). Cumulatively, these data show that the FA core complex
is much more active and more specific than isolated FANCL.
Purified FA core complex catalyzes only the physiologically
relevant formation of monoubiquitin linkages because a single
discrete ubiquitinated FANCD2 species is observed (Figure 3).
A B Figure 3. Purified FA Core ComplexMonou-
biquitinates FANCD2 in the Context of
FANCI and DNA
(A) Schematic of the in vitro ubiquitination assay.
Assays were monitored by western blotting with
anti-His to detect His-tagged FANCI and FANCD2
or anti-HA to detect HA-tagged ubiquitin.
(B) Monoubiquitination of FANCD2 and the FANCI-
FANCD2 complex in the absence or presence of
50-flapped DNA after 90 min at 30C. FANCI and
FANCD2 show mild cross-reactivity with anti-
HA. Autoubiquitination of FANCL and UBE2T
are labeled. FA core complex concentration is
200 nM. See Figure S1D for analysis after an
additional 12 hr at room temperature.
See also Figure S1.
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Purification and Activity of FA Core ComplexIn contrast, reactions containing isolated FANCL demonstrate
weak poly- or multiple monoubiquitination activity, seen as
higher-molecular-weight smears on the gel (Figure S2A, HA
blot lanes 8 and 9). Also unlike the FA core complex (Figure 3B,
lanes 2 and 5), recombinant FANCL has FANCD2 monoubiquiti-
nation activity even in the absence of FANCI (see Figure S3A, HA
blot lane 3) (Alpi et al., 2008; Sato et al., 2012). Altogether, these
data suggest that other FA core complex subunits most likely
contribute to activity, substrate recognition, and specificity
required to retain exclusive monoubiquitination activity on
FANCD2 in the context of FANCI.
UBE2T, but Not UBE2W, Functions as a Specific E2 for
FANCD2 Monoubiquitination In Vivo and In Vitro
Although UBE2T is established as an E2 for FANCD2 monoubi-
quitination in vivo (Alpi et al., 2007, 2008; Machida et al., 2006),
UBE2W also binds FANCL (Alpi et al., 2008; Zhang et al., 2011).
We found that, in assays with FANCL, UBE2W weakly monoubi-
quitinates FANCD2 and FANCI, but this was not dependent on
the presence of the FANCI-FANCD2 complex (Figure S3A, lanes
4, 6, 10, and 12), stimulated by DNA (Figure S3A, lanes 6 and 12),
and not site specific (Figure S3A, lanes 26 and 38). Similar obser-
vations were made in assays with the FA core complex (Fig-
ure S4B). These data indicate that UBE2Wmediates nonspecific
monoubiquitination of the FANCI-FANCD2 complex in vitro. To
investigate its in vivo role, we deleted UBE2W in DT40 cells and
examined FA pathway activity (Figures S3C and S3D). DUBE2W
cells did not display significant cellular sensitivity to MMC (Fig-
ure S3E) and had normal levels of basal and MMC-induced
FANCD2 monoubiquitination, unlike DUBE2T or DFANCB cells
(Figure S3F). Along with previous work (Alpi et al., 2007; Machida
et al., 2006), our results emphatically show that UBE2W does not
play a major role in site-specific monoubiquitination of FANCD2
and that UBE2T is the major E2 in the FA pathway.Molecular Cell 54, 858–FANCI Is Not Ubiquitinated by a
Purified FA Core Complex
FANCI monoubiquitination is presumed
to be catalyzed by the FA core complex,
but this modification is dispensable for
DNA repair (Ishiai et al., 2008; Sims
et al., 2007; Smogorzewska et al., 2007).We only observed weak FANCI monoubiquitination in our
assay that was not affected by the presence of FANCD2 or
DNA and did not significantly increase over time, suggesting
that it may not be physiologically relevant (HA blots in Figures
3B, S1D, and S2). Therefore, the factors enhancing FANCI
monoubiquitination remain elusive but could include an
alternate chromatin and/or DNA context or interplay with ATR-
dependent FANCI phosphorylation (Ishiai et al., 2008; Tomida
et al., 2013).
Purified FA Core Complex Lacking FANCC and FANCE
Retains In Vitro Activity
FA can result from the loss of a single FA core complex subunit,
which is thought to interfere with the integrity of the entire
complex. To further investigate the stability and in vitro activity
of the FA core complex, we deleted the FANCC gene (Niedz-
wiedz et al., 2004) in DFANCB/FANCB-GS cells. Cellular frac-
tionation before and after FANCC deletion revealed that
although FANCD2 monoubiquitination was significantly im-
paired, a residual amount was detectable in the chromatin-
bound fraction after MMC treatment (Figure 5A, lane 8). This
suggested that even with the loss of FANCC, the FA complex
remains partially competent for FANCD2 monoubiquitination
in vivo. To verify this, we purified the FA core complex from the
DFANCC/DFANCB/FANCB-GS cell line. This yielded a prepara-
tion specifically lacking the deleted FANCC gene product and its
known binding partner FANCE (Figure 5B) (Pace et al., 2002; Ta-
niguchi and D’Andrea, 2002). FANCF, thought to bridge the
FANCC-FANCE and FANCA-FANCG subunits (Le´veille´ et al.,
2004), was also depleted. Thus, although FANCC deletion
partially destabilized the complex through loss of FANCE and
FANCF, the remaining subunits (FANCA, FANCB, FANCG,
FANCL, and FAAP100) were stably associated and the yield of
purified complex was similar to wild-type cells.869, June 5, 2014 ª2014 The Authors 861
A B
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Figure 4. The FA Core Complex Has Higher Activity and Specificity than Isolated FANCL
(A) Titration of the FA core complex in a 2-fold dilution series (lanes 2–5) is compared to isolated FANCL (lanes 8 and 9) in themonoubiquitination assay after 90min
at 30Cmonitored by western blotting. See Figure S2A for analysis after an additional 12 hr at room temperature. The bottom panel is a silver-stained gel showing
the relative amounts of isolated FANCL (1 mM) used for the reactions in lanes 8 and 9 and FANCL in the FA core complex (200 nM) at the highest concentration
in lanes 5–7. The full gel is shown in Figure S2B.
(B) Time course of FANCD2 monoubiquitination by the FA core complex (top) and a molar equivalent amount of recombinant FANCL (bottom). Anti-His western
blots for detecting His-tagged FANCI and FANCD2 are shown. Anti-HA western blots of the same samples to detect HA-ubiquitin are shown in Figure S2C.
(C) The amounts of FANCD2-Ub in the reactions shown in (B) were quantified and are plotted as a percentage of total FANCD2 (ubiquitinated FANCD2/total
FANCD2).
(D) Monoubiquitination of WT and nonubiquitinatable (lysine to arginine, KR) mutants of FANCI and FANCD2 by 100 nM core complex in the presence of DNA
over 3 hr at 30C.
See also Figures S2 and S3.
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Purification and Activity of FA Core ComplexSurprisingly, when we assayed the FA core complex lacking
FANCC and FANCE, FANCD2 monoubiquitination activity was
comparable to the wild-type complex (Figure 5C). There was
no discernable difference in the rate of monoubiquitination, the
effect of DNA, or the lack of FANCI monoubiquitination. These
data demonstrate that the FANCC-FANCE subcomplex is
dispensable for the overall stability and catalytic activity of the
FA core complex.
Residual In Vivo FANCD2 Monoubiquitination Activity
after Deletion of FANCA, FANCC, FANCF, or FANCG but
Not FANCB, FANCL, or FAAP100
Wewere surprised that purified FA core complex lacking FANCC
and FANCE (and with substantially reduced FANCF) had normal
activity in vitro. To understand the roles of other core complex
subunits, we took further advantage of the genetic tractability
of the DT40 system. Specifically, we examined FANCD2 ubiqui-862 Molecular Cell 54, 858–869, June 5, 2014 ª2014 The Authorstination in vivo in a panel of DT40 cell lines in which each individ-
ual FA core complex subunit, with the exception of FANCE, had
been deleted. Although very weak in comparison to wild-type or
DFANCM cells, residual chromatin-associated FANCD2monou-
biquitination is still present in cells lacking FANCA, FANCC,
FANCF, or FANCG (Figure 5D, bottom two panels). This is an un-
expected result, given that work on human FA patient-derived
lymphocytes shows an absence of FANCD2 monoubiquitination
in all of the FA core complex complementation groups except
FANCM (Garcia-Higuera et al., 2001; Singh et al., 2009).
In contrast, cells lacking FANCB, FANCL, or FAAP100 com-
pletely lost the ability to ubiquitinate FANCD2 (Figure 5D). This
is consistent with FANCL’s role as the E3 ligase and the direct
interaction of these three subunits (Ling et al., 2007). This surpris-
ing result demonstrates that, at least in DT40 cells, FANCB,
FANCL, and FAAP100 are the only subunits whose deletion re-
sults in complete loss of FANCD2monoubiquitination. To further
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Figure 5. Deletion of FANCCDoesNot Impact the In Vitro Ubiquitin Ligase Activity of the FACore Complex, and the FANCB-FANCL-FAAP100
Subcomplex Is Essential for Monoubiquitination In Vivo
(A)Western blots ofDFANCB/FANCB-GS (DB/B-GS) andDFANCB/FANCB-GS/DFANCC (DB/B-GS/DC) cells (with andwithoutMMC treatment) after subcellular
fractionation into cytonucleoplasmic (S) and chromatin (P) fractions with anti-FANCD2. Low and high exposures are shown.
(B) SDS-PAGE and silver stain analysis of the FA core complex purified from DB/B-GS and DB/B-GS/DC cell lines in parallel. The inset shows loss of FANCC and
FANCE proteins and reduction of FANCF.
(C) In vitro ubiquitination assays of the FA core complexes (80 nM) shown in (B) monitored by western blotting against FANCD2 and FANCI (anti-His) and
ubiquitin (anti-HA).
(D) DT40 cell lines with FA core complex subunit deletions were treated with MMC, fractionated into cytonucleoplasmic (S) and chromatin (P) fractions and
subjected to western blotting with anti-FANCD2. An additional high exposure is shown for the bottom panel.
(E and F) Cellular sensitivity of WT, DFANCA, DFANCG, DFANCB, DFANCC, and DFANCF DT40 cells after exposure to indicated doses of MMC. The mean
percentage of survival ± SEM of three independent colony-formation assays are plotted relative to untreated cells. DFANCB cl. 31 is the unloxed parental line to
DFANCB cl. 5.
See also Figure S4.
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Figure 6. In Vitro FANCD2 Monoubiquitina-
tion by the B-L-100 Subcomplex
(A) Coomassie Blue SDS-PAGE analysis of purified
chicken recombinant B-L-100.
(B) FANCD2 monoubiquitination by the B-L-100
subcomplex and isolated FANCL in 2-fold dilution
series starting at 0.8 mM in the absence and
presence of DNA analyzed by western blotting
with anti-His.
(C) The amounts of FANCD2-Ub in the reactions
shown in (B) were quantified and plotted as
a percentage of total FANCD2 (ubiquitinated
FANCD2/ total FANCD2).
(D) Schematic of different DNA substrates. ss,
single-stranded; ds, double-stranded.
(E and F) FANCD2 monoubiquitination by the B-L-
100 subcomplex (E) or FA core complex (F) in the
presence of 1 mM DNA substrates indicated in (D).
Reactions were performed for 90 min with 200 nM
B-L-100 or FA core complex. Right, a comparison
between 49-mer ssDNA and polyT DNA.
See also Figure S5.
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mammalian FA pathway, we examined FANCD2 monoubiquiti-
nation in mammalian cell lines (human, mouse, and hamster)
with targeted disruption of a FA subunit and compared this to
isogenic wild-type cell lines. Chromatin-bound FANCD2 from
cells with targeted disruption of FANCG, but not FANCB, retains
residual FANCD2 ubiquitination (Figure S4). Furthermore, resid-
ual FANCD2 monoubiquitination has recently been demon-
strated in a panel of human cell lines with targeted disruption
of FA core complex subunits with the exception of DFANCB,
DFANCL, or DFAAP100, which have no monoubiquitination
activity (Huang et al., 2014).
Ubiquitinated FANCD2 is thought to act as an adaptor for DNA
repair enzymes, allowing incision at sites of DNA crosslinks and
promoting repair by homologous recombination (Crossan and
Patel, 2012). Therefore, residual FANCD2 ubiquitination in864 Molecular Cell 54, 858–869, June 5, 2014 ª2014 The Authorscertain FA core complex subunit
knockout cells (Figure 5D) would be ex-
pected to show attenuated cellular sensi-
tivity to DNA damage in comparison to
knockout cells with no FANCD2 ubiquiti-
nation. To test this, we exposed DT40
cells to MMC and determined their sur-
vival. As shown in Figures 5E and 5F,
DFANCB cells are more sensitive to
MMC thanDFANCA,DFANCG,DFANCC,
and DFANCF cells. Thus, the amount of
FANCD2 monoubiquitination correlates
with MMC sensitivity in cells.
Recombinant B-L-100
Monoubiquitinates FANCD2
FANCC and FANCE are biochemically
dispensable for FANCD2 ubiquitination
by a purified FA core complex (Figure 5C),
and only FANCB, FANCL, and FAAP100are genetically essential in vivo for monoubiquitination (Fig-
ure 5D). Therefore, we reasoned that FANCB, FANCL, and
FAAP100 could constitute the catalytic core of the FA core com-
plex. We expressed and purified a complex of B-L-100 (Fig-
ure 6A). In vitro reconstitution assays show that B-L-100 is
more active than FANCL alone (Figures 6B and 6C). In the pres-
ence of DNA, the B-L-100 subcomplex is 5- to 6-fold more active
at ubiquitinating FANCD2 than isolated FANCL and thus compa-
rable with the intact core complex. However, unlike the intact
core complex, weak FANCD2 ubiquitination in the absence of
FANCI (Figure S5A) and very weak multiple ubiquitination could
be observed (Figure S5B).
Interestingly, the B-L-100 subcomplex retained significant
activity in the absence of DNA (compare Figures 4C and 6C).
To gain insight into themechanism of DNA stimulation, we tested
a panel of DNAs with different structures for their abilities to
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Figure 7. USP1 Deletion Restores FANCD2 Monoubiquitination but Not Sensitivity to MMC in DFANCC Cells
(A) DT40 cell lines with indicated genotypes were treated withMMC, fractionated into cytonucleoplasmic (S) and chromatin (P) fractions, and analyzed bywestern
blotting with anti-FANCD2.
(B) Cellular sensitivity of DT40 cells after exposure to indicated doses of MMC. The mean percentage of survival ± SEM of three independent colony-formation
assays are plotted relative to untreated cells.
(C) The FA core complex is comprised of multiple modules. B-L-100 (green) is central to the monoubiquitination step. The A-G (orange) and C-E-F (blue) modules
may affect this catalytic function through regulatory or stabilizing roles. They may also serve distinct functions independent of ubiquitination in FA DNA repair.
Subunits shown to be dispensable for ubiquitination in vivo are in gray.
See also Figure S6.
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DNA substrates stimulated the reaction (Figures 6D–6F and
S5C). Intriguingly, unstructured polyT DNA did not stimulate
the activity of B-L-100 or the intact core complex to the same
extent as other DNAs (Figures 6E and 6F). In comparison to
B-L-100, the intact core complex has lower basal FANCD2
monoubiquitination activity in the absence of DNA. This sug-
gests DNA may be required to activate the FA core complex.
USP1 Deletion Permits Accumulation of FANCD2
Monoubiquitination in Cells with Residual Activity
The deubiquitinase enzyme USP1, in complex with UAF1, has
been shown to deubiquitinate FANCD2 (Nijman et al., 2005).
USP1 disruption leads to constitutive, chromatin-targeted
monoubiquitinated FANCD2 (Kim et al., 2009; Oestergaard
et al., 2007). To understand the functional importance of weak
residual FANCD2 ubiquitination found in a FA-core-complex-
defective cell line, we targeted both USP1 and FANCC in DT40
cells (Figure S6A). Strikingly, FANCD2 monoubiquitination was
restored in the double mutant, supporting the observation of a
partially active core complex in DFANCC cells (Figures 7A,S6B, S6D, and S6E). However, ubiquitination was not induced
uponDNAdamage, andmonoubiquitinated FANCD2was largely
chromatin bound, though it was not as heavily enriched on chro-
matin as in DUSP1 cells (Oestergaard et al., 2007). Another
target of USP1 activity, PCNA, was not affected in the double
mutant (Figures S6B and S6C). As previously reported (Oester-
gaard et al., 2007), a DUSP1/DFANCLmutant showed no rescue
of FANCD2 ubiquitination, given that the catalytic activity of the
core complex was fully compromised (Figure 7A).
Although monoubiquitinated FANCD2 was present in DUSP1/
DFANCC cells, the double mutant was more sensitive to MMC
than either single mutant (Figure 7B). In comparison, we have
previously shown that DUSP1/DFANCL cells are not more sensi-
tive to DNA damage than the FANCLmutant alone (Oestergaard
et al., 2007). Altogether, these results support the notion of
epistasis between the gene products essential for monoubiquiti-
nation (FANCB, FANCL, and FAAP100) and deubiquitination
(USP1) events in crosslink repair. Even though the residual
FANCD2 ubiquitination in DFANCC cells is sufficient to partially
attenuate MMC sensitivity in comparison to DFANCB cells that
entirely lack ubiquitination (Figure 5F), simply restoring theMolecular Cell 54, 858–869, June 5, 2014 ª2014 The Authors 865
Molecular Cell
Purification and Activity of FA Core Complexubiquitinated FANCD2 (by deleting DUSP1) in this context is not
sufficient to restore a functional FA DNA repair response.
DISCUSSION
In this study, we have combined a stringent biochemical purifica-
tion strategy with genetic analyses in DT40 cells to establish a
system for mechanistic interrogation of the FA pathway. We
report the purification of a native FA core complex and the recon-
stitution of its FANCD2 monoubiquitination activity in vitro. The
intact complex is more active and specific than the FANCL sub-
unit alone. Within the intact complex, we identify a minimal sub-
complex of just three subunits (B-L-100) that constitutes the
essential machinery required for robust FANCD2 ubiquitination
(Figure 7C). Understanding how FANCB and FAAP100 enhance
the activity of FANCL in this subcomplex will be an important di-
rection for future study. They may stabilize the FANCL protein or
support a conformation permissive for binding to both UBE2T
and FANCD2 in order to enhance substrate recognition, posi-
tioning, and modification.
Surprisingly, even thoughmutation in any subunit was thought
to destabilize and inactivate the FA core complex in patients, not
all subunits are required for monoubiquitination. We verified the
catalytic competence of FA core complex lacking FANCC with
both in vivo (Figures 5A, 5D, and 7A) and in vitro (Figure 5C)
methods. The reduced level of in vivo ubiquitination in DFANCC
cells may result from inefficient regulation, subcellular localiza-
tion, or unproductive substrate binding (Gordon et al., 2005;
Pace et al., 2002). It is possible that FANCC and other core com-
plex subunits directly regulate the monoubiquitination reaction
(positively or negatively), help recruit and/or position substrates,
or indirectly control the catalytic activity in vivo through stability
and/or localization of the FA core complex. Alternatively, given
that a mutation in any single core complex component (not just
FANCB, FANCL, or FAAP100) manifests in FA, the core complex
or its subcomplexes could have additional roles in DNA repair
independent of ubiquitination (Matsushita et al., 2005). Never-
theless, our work provides clear evidence that the B-L-100
subcomplex is the monoubiquitination module because DT40
cells that have a deletion of any other subunit retain residual
FANCD2 monoubiquitination. To date, residual FANCD2 mono-
ubiquitination has not been detected in FA patient-derived cell
lines, although it is observed in gene-targeted mammalian cells
(Figure S4).
A number of different DNA structures stimulate the in vitro
ubiquitination of FANCD2. This is not unexpected for two rea-
sons. First, the FA pathway is activated in vivo by a diverse range
of DNA-damaging and replication-stress-inducing agents that
are likely to elicit different DNA conformations, structures, and
adducts (Garcia-Higuera et al., 2001; Howlett et al., 2005). Sec-
ond, studies in Xenopus egg extracts reveal that an array of
exogenous DNA substrates can induce FANCI/FANCD2monou-
biquitination (Ra¨schle et al., 2008; Sareen et al., 2012; Sobeck
et al., 2007). Given that unstructured polyT had a reduced effect,
structured and/or duplex DNA may be required to promote a
conformational change that makes the K563 acceptor lysine in
FANCD2 accessible. This may be mediated by FANCI, which is
known to bind FANCD2 and structured DNA substrates (Joo866 Molecular Cell 54, 858–869, June 5, 2014 ª2014 The Authorset al., 2011; Longerich et al., 2009; Sato et al., 2012; Yuan
et al., 2009).
Although our purification shows that the intact complex exists
and can be purified, independent of induced DNA damage (Fig-
ure 2B) (Alpi et al., 2007), the subunits were present in nonuni-
form amounts (Table S1) and could be grouped based on their
relative abundances: B-L-100, C-E-F, and A-G (Figure 7C). The
existence of FA subcomplexes is consistent with earlier work
(Garcia-Higuera et al., 2001, 2000; Ling et al., 2007; Medhurst
et al., 2006; Thomashevski et al., 2004) and could represent
different stoichiometries within the assembled complex, assem-
bly intermediates, and/or functional modules. For example,
although FANCL has been shown to directly bind FANCD2 and
FANCI (Cole et al., 2010; Hodson et al., 2011; Seki et al.,
2007), C-E-F could represent a functional module that regulates
these substrate interactions via FANCE-FANCD2 associations
or impinges upon substrate accessibility by USP1 (Gordon
et al., 2005; Nookala et al., 2007; Pace et al., 2002; Polito
et al., 2014).
FANCF could act as a scaffold to anchor both the A-G module
(Le´veille´ et al., 2004) and the FANCM-FAAP24-FAAP10-FAAP16
module implicated in chromatin targeting, suppression of cross-
over recombination, and checkpoint signaling (Collis et al., 2008;
Deans and West, 2009; Rosado et al., 2009). The A-G module
may also function in chromatin targeting of the complex sug-
gested by data showing intrinsic DNA binding of FANCA (Yuan
et al., 2012) and the association of FANCA with FAAP20, a ubiq-
uitin-binding-zinc-finger-containing protein that binds ubiquitin
chains assembled by RNF8 and promotes chromatin targeting
of the core complex and FANCD2 in vivo (Ali et al., 2012; Leung
et al., 2012; Yan et al., 2012).
Our finding that combinedUSP1 and FANCC deletion restores
monoubiquitinated FANCD2 but cannot rescue MMC sensitivity
challenges the broadly held view of a linear FA pathway in which
substrate ubiquitination by the FA core complex alone leads to
DNA repair. The ubiquitinated FANCD2 in DUSP1/DFANCC
cells, although near wild-type levels, is substantially chromatin
bound and not induced by DNA damage. Clearly, the ubiquitina-
tion and deubiquitination of FANCD2 must be a tightly regulated
response in a functional FA pathway. ThatDUSP1/DFANCC cells
are more sensitive than either single mutant suggest that the FA
core complexmay serve other functions in DNA repair in addition
to ubiquitination. Elucidating these functions may ultimately
explain why the FA core complex has such a highly conserved
yet poorly understood macromolecular composition.
Our work establishes a comprehensive genetic, biochemical,
and structural framework to dissect the mechanism of monoubi-
quitination by the FA core complex. Using this system, it may
now be possible to interrogate the activity of the complex from
different physiological states, different subcellular locations, in
response to cell-cycle progression and, critically, in response
to DNA damage when the FA pathway is activated.EXPERIMENTAL PROCEDURES
Detailed purification protocols and generation of cell lines are described in the
Supplemental Information. The tandem affinity purification scheme is modified
from Bu¨rckstu¨mmer et al. (2006) and was performed at 4C. In brief, to purify a
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Purification and Activity of FA Core ComplexFA core complex, DB/B-GS, or DB/B-GS/DC DT40 cells were lysed in GS
buffer (50 mM HEPES [pH 8.0], 150 mM NaCl, 5% glycerol, 0.1% Igepal CA-
630, 1.5 mM MgCl2, 25 mM NaF, 2 mM Na3VO4, 40 mM b-glycerophosphate,
1 mM phenylmethylsulfonyl fluoride, 10 mM b-mercaptoethanol [BME], and
PhosSTOP inhibitor cocktail [Roche] and protease inhibitor cocktail) by pass-
ing through 19 G and 25 G needles multiple times. After clarification, the lysate
was incubated with IgG-agarose beads (Sigma-Aldrich) for 2 hr with gentle
rotation. The beads were washed with wash buffer (50 mM HEPES [pH 8.0],
150 mM NaCl, 10% glycerol, and phosphatase/protease inhibitors) and then
wash buffer supplemented with 5 mM BME. To elute, the beads were incu-
bated with TEV protease at 16C for 2 hr with gentle agitation. For the second
affinity step, the supernatant was incubated with Ultralink Streptavidin Plus
Resin (Pierce) with gentle rotation for 1 hr, washed with 100 bed volumes of
wash buffer supplemented with 5 mM BME, and eluted with wash buffer sup-
plemented with 3 mM BME and 6 mM D-biotin (Sigma-Aldrich). The complex
was resolved by SDS-PAGE and analyzed by Coomassie, silver (Sigma-
Aldrich), or SYPRO-Ruby (Lonza) staining. Bands were excised, digested,
and identified by tandemmass spectrometry (data not shown) with multiple in-
dependent purifications. Themajor species identified in each band is indicated
in Figure 2B. Purified complex was used fresh, immediately after purification,
for downstream biochemical analyses. A titration against known concentra-
tions of recombinant FANCL was used to approximate the concentration of
prepared FA core complex (normalized to its FANCL band) on SDS-PAGE.
We estimate that, from a 3 g DT40 cell pellet (2–4 L cell culture), we purified
5 mg FA core complex.
Western blotting was performed after SDS-PAGE on 4%–12% Bis-Tris gels
or 3%–8% Tris-Acetate gels (Life Technologies) and transfer to polyvinylidene
fluoride membranes (Millipore). The antibodies used were HRP-conjugated
anti-HA (F-7, Santa Cruz Biotechnology), HRP-conjugated anti-His (H-3,
SCBT), anti-b-actin (AC-15, Sigma-Aldrich), anti-chicken FANCG (Alpi et al.,
2007), anti-chicken FANCM (Mosedale et al., 2005), or anti-chicken FANCD2
(gift of Michael Hodskinson, Medical Research Council Laboratory of Molecu-
lar Biology).
For ubiquitination assays, reactions in 10–20 ml volumes were performed in a
buffer comprising 50 mM HEPES (pH 7.5), 64 mM NaCl, 4% glycerol, 5 mM
MgCl2, 2 mMATP, and 0.5mM dithiothreitol. In all reactions, 75 nM E1 (Boston
Biochem) and 1 mM E2 (UBE2T or UBE2W) enzymes, 1 mM substrate (FANCI,
FANCIK525R, FANCD2, and FANCD2K563R), 50 mM 50-flapped DNA (nucleotide
concentration, unless otherwise stated), and 20 mMHA-ubiquitin (Boston Bio-
chem) were used unless otherwise stated. E3 (FANCL or FA core complex)
concentrations are indicated in the figures. Optimal E2 and FANCL concentra-
tions were determined by titrations. All reactions were incubated at 30C for
90 min (or for indicated times as part of a time course) and quenched by the
addition of LDS sample buffer (Life Technologies). Samples were analyzed
by western blotting.
Additional details of experimental procedures are contained in the Supple-
mental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.molcel.2014.05.001.
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